Naproxen for Cellulitis

(NVP Trial)

This trial tests whether adding naproxen, a common pain reliever, to antibiotics can speed up recovery for people with cellulitis. Cellulitis is a painful skin infection that causes redness and swelling. Participants will receive either naproxen with antibiotics or a placebo with antibiotics to determine which treatment is more effective. Those diagnosed with cellulitis and eligible for outpatient treatment with oral antibiotics may be suitable candidates for this study. The goal is to find a fast and effective treatment for cellulitis that reduces pain and improves recovery time. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.

Research has shown that naproxen, a common pain reliever, is generally safe for short-term use. One study found that combining naproxen with antibiotics was safe for people with cellulitis, a skin infection. In that study, naproxen reduced swelling without causing serious side effects.

Naproxen is also used for other health issues, which supports its safety profile. However, like all similar medications, it can cause side effects, particularly with long-term use. These side effects may include stomach upset or an increased risk of heart problems, but such risks are more likely with prolonged use, not the short-term use typical for treating cellulitis.

Naproxen is unique because it offers an anti-inflammatory approach to treating cellulitis, which is typically managed with antibiotics like cephalexin alone. Most treatments for cellulitis focus solely on targeting the bacterial infection. However, Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), adds the potential to reduce inflammation and pain associated with the condition, potentially speeding up recovery. Researchers are excited about this combined approach because it could enhance patient comfort and improve outcomes more quickly than antibiotics alone.

Research has shown that taking naproxen with antibiotics might reduce swelling and speed up recovery for people with cellulitis. In this trial, one group of participants will receive naproxen and cephalexin, while another group will receive a placebo with cephalexin. Some studies have found that anti-inflammatory treatments can accelerate symptom resolution, with some patients fully recovering in just 4 to 5 days. Specifically, one study found that combining cefazolin and naproxen was more effective than using just one treatment. Although not all studies show a difference at every point in time, the potential for quicker healing and less pain makes naproxen a promising addition to standard antibiotic treatment for cellulitis.²³⁵⁶⁷